Free Summary Paper - Genzyme as acquisition target: Opportunities and risks in its business and key niche markets
- Why has Genzyme’s business attracted the attention of large pharmaceutical companies?
- What are the uncertainties that a potential acquirer must consider?
- What are the prospects for its long dominant position in niche enzyme replacement therapies?
Round-up
Register to receive Decision Resources' round-up, a summary email of the company's latest research, products, and special offers.
Decision Resources Group companies include: